Last reviewed · How we verify
Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause
Approved treatments
- Menest · Pfizer Inc.
Esterified estrogens, sold under the brand names Estratab and Menest, are used for hormone therapy and cancer treatment.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause treatment landscape brief
- Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause treatment updates RSS
Frequently asked questions about Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause
What drugs treat Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause?
Tracked treatments include Menest.
What is the treatment for Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause?
Standard treatment for Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause includes Menest. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause patent cliff · Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause CI report
- Treatment: Menest · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing